Skip to main content
PACIFIC EDGE LIMITED logo

PACIFIC EDGE LIMITED — Investor Relations & Filings

Ticker · PEB ISIN · NZPEBE0002S1 LEI · 9845007EDCF068FFEA12 ASX Professional, scientific and technical activities
Open in API
Filings indexed 747 across all filing types
Latest filing 2023-04-30 Report Publication Anno…
Country NZ New Zealand
Listing ASX PEB

About PACIFIC EDGE LIMITED

https://www.pacificedgedx.com/

Pacific Edge Limited is a cancer diagnostics company specializing in the development and commercialization of non-invasive molecular diagnostic tests. The company's primary product suite, Cxbladder, utilizes advanced mRNA biomarker technology to detect and monitor bladder cancer from urine samples. These genomic tests are designed to assist clinicians in the evaluation of patients presenting with hematuria and in the ongoing surveillance of patients previously diagnosed with the disease. By providing high sensitivity and negative predictive value, the Cxbladder suite helps to accurately rule out urothelial carcinoma, potentially reducing the requirement for invasive clinical procedures such as cystoscopy. The company focuses on integrating its diagnostic tools into standard clinical pathways to improve patient outcomes and healthcare efficiency.

Recent filings

Filing Released Lang Actions
Pacific Edge Full Year Result to be Announced 25 May 2023 1
Report Publication Announcement Classification · 95% confidence The document is a company announcement dated 1 May 2023, stating that the full year results for the fiscal year ending 31 March 2023 will be announced on 25 May 2023. It includes details about an upcoming investor and analyst conference call and provides contact information. The document does not contain any actual financial data or detailed results; it is merely an announcement of the timing of the forthcoming full year results and the related conference call. The document length is short (2505 characters) and fits the pattern of a report publication announcement rather than the report itself. Therefore, according to the 'Menu vs Meal' rule, this document should be classified as a Report Publication Announcement (RPA).
2023-04-30 English
Quarterly Update – Q4 23 Test Volumes Reach New Record
Management Reports Classification · 95% confidence The document is a detailed investor update from Pacific Edge Limited dated April 2023. It includes a letter from the CEO discussing the company's financial year performance ending March 2023, test volume statistics, Medicare coverage updates, strategic account progress, and new market developments. It contains substantive financial and operational data, including quarterly and annual test volumes, growth percentages, and strategic initiatives. The document also mentions upcoming annual shareholder meeting details and references to financial results to be released later. The length is about 15,000 characters, indicating a comprehensive report rather than a brief announcement. The content focuses on financial performance, business trends, and strategic progress over the fiscal year, consistent with a management report or detailed financial update. It is not a full annual report (10-K) but rather a detailed management discussion and analysis type document. Therefore, the best fitting category is Management Reports (MDA).
2023-04-17 English
Quarterly Update Q4 23 Test Volumes Reach New Record 12 pages 3.2MB
Interim / Quarterly Report Classification · 95% confidence The document is a detailed quarterly investor update from Pacific Edge, focusing on test volumes, Medicare coverage updates, strategic progress, and operational highlights for the fourth quarter of fiscal year 2023 (Q4 23). It contains substantive financial and operational data, including test volume statistics, growth percentages, and strategic initiatives. The document is not merely an announcement or a brief summary but provides comprehensive quarterly performance information and business updates. It is not an earnings release (which typically is shorter and focused on headline financial results), nor is it an annual report or audit report. The presence of detailed quarterly data and analysis aligns with the definition of an Interim / Quarterly Report (IR). Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q4 2023
2023-04-17 English
SPH Notice – ANZ New Zealand Investments Limited
Major Shareholding Notification Classification · 100% confidence The document is a detailed disclosure of movements in substantial shareholdings, specifically noting changes of 1% or more in the holdings of ANZ New Zealand Investments Limited, ANZ Bank New Zealand Limited, and ANZ Custodial Services New Zealand Limited. It references the Financial Markets Conduct Act 2013 and provides extensive transaction details including on-market and off-market trades, share counts, and percentages held. This type of document is a notification of changes in significant share ownership levels, which aligns with the definition of Major Shareholding Notification (MRQ). The document is not an annual report, earnings release, or any other financial report type, but a regulatory disclosure about shareholding changes.
2023-04-17 English
Pacific Edge Provides Update on Kaiser EMR Integration
Capital/Financing Update Classification · 85% confidence The document is a company announcement providing an update on the integration of a product (Cxbladder) into Kaiser Permanente's Electronic Medical Records system. It includes statements from company executives and a medical professional, describing progress milestones and future plans for updates. There are no financial statements, regulatory filings, voting results, or detailed financial data. The document is relatively short (3837 characters) and serves as a progress update rather than a formal financial or regulatory report. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is an operational update related to a project and ongoing shareholder communication. The best fitting category is Capital/Financing Update (CAP) as it relates to a significant project integration update that impacts company operations and potentially its capital deployment, and the company states it will provide quarterly shareholder updates on progress. Confidence is high given the clear nature of the update and absence of other report types.
2023-03-30 English
Pacific Edge Provides Update on Kaiser EMR Integration 1
Capital/Financing Update Classification · 85% confidence The document is a company announcement providing an update on the integration of a product (Cxbladder) into Kaiser Permanente's Electronic Medical Records system. It discusses project milestones, ongoing progress, and future updates. There are no financial statements, regulatory filings, voting results, or detailed financial data. The document is relatively short (3837 characters) and serves as a progress update rather than a formal financial or regulatory report. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. The content is best classified as a Capital/Financing Update (CAP) because it relates to a significant project integration that impacts the company's operations and future prospects, and the company commits to providing quarterly shareholder updates on progress, which aligns with ongoing capital or project updates.
2023-03-30 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.